MATTHEW BOWLES: Open Payments
NPI 1942236948 · SALEM, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,726 in 77 payments from 15 companies in 2025. Trend: 2023 $1,776 · 2024 $1,490 · 2025 $1,726
Food & beverage: $1,726
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 20 | $628 |
| Novartis Pharmaceuticals Corporation | 10 | $202 |
| E.R. Squibb & Sons, L.L.C. | 7 | $174 |
| Amgen Inc. | 9 | $137 |
| BridgeBio Pharma, Inc. | 5 | $120 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $69 |
| PFIZER INC. | 4 | $64 |
| Merck Sharp & Dohme LLC | 3 | $51 |
| SCPHARMACEUTICALS INC. | 3 | $47 |
Products named: LUX-Dx Insertable Cardiac Monitor, LEQVIO, CAMZYOS, REPATHA, Attruby, WATCHMAN FLX, LifeVest, ELIQUIS.
Industry payments across VA — which companies pay providers there.
